Announcement by SNB Capital Company the availability of the Quarterly statement of AlAhli REIT Fund 1 for the period ending on 2025-03-31
SNB Capital announces the availability of AlAhli REIT Fund (1) quarterly Fact Sheet for the period ended 31 March 2025G. A copy of the Fact Sheet can be obtained through the link
http://alahlicapital.com/ar/Q1%202025%20English%20Factsheet.pdf
SNB Capital announces the availability of AlAhli REIT Fund (1) quarterly Fact Sheet for the period ended 31 March 2025G. A copy of the Fact Sheet can be obtained through the link
1
http://alahlicapital.com/ar/Q1%202025%20English%20Factsheet.pdf
http://alahlicapital.com/ar/Q1%202025%20English%20Factsheet.pdf
http://alahlicapital.com/ar/Q1%202025%20English%20Factsheet.pdf
http://alahlicapital.com/ar/Q1%202025%20English%20Factsheet.pdf
SNB Capital announces the availability of AlAhli REIT Fund (1) quarterly Fact Sheet for the period ended 31 March 2025G. A copy of the Fact Sheet can be obtained through the link
1
http://alahlicapital.com/ar/Q1%202025%20English%20Factsheet.pdf
http://alahlicapital.com/ar/Q1%202025%20English%20Factsheet.pdf
http://alahlicapital.com/ar/Q1%202025%20English%20Factsheet.pdf
SNB Capital Company announces a conflict of interest in a number of investment funds
SNB Capital Company announces a conflict of interest in the following funds:
SNB Capital Saudi Trading Equity Fund
SNB Capital GCC Trading Equity Fund
SNB Capital GCC Growth and Income Fund
SNB Capital Freestyle Saudi Equity Fund
SNB Capital Saudi Small and Mid-Cap Equity Fund
SNB Capital Saudi Large-Mid Cap Equity
Fund
SNB Capital Saudi Nomu Market Fund
SNB Capital Al Ataa Saudi Equity Fund
SNB Capital Healthcare & Education Sectors Fund
SNB Capital Arab Markets Equity Fund
SNB Capital King Saud University Waqf Fund
Ehsan Waqf Fund
As follows: Participating in the IPO of Specialized Medical Company whereas SNB Capital Company is the Lead Manager, one of the Financial Advisors, Bookrunners and Underwriters. The fund board approval was obtained.
SNB Capital Company announces a conflict of interest in the following funds:
- SNB Capital Saudi Trading Equity Fund
- SNB Capital GCC Trading Equity Fund
- SNB Capital GCC Growth and Income Fund
- SNB Capital Freestyle Saudi Equity Fund
- SNB Capital Saudi Small and Mid-Cap Equity Fund
- SNB Capital Saudi Large-Mid Cap Equity
Fund
- SNB Capital Saudi Nomu Market Fund
- SNB Capital Al Ataa Saudi Equity Fund
- SNB Capital Healthcare & Education Sectors Fund
- SNB Capital Arab Markets Equity Fund
- SNB Capital King Saud University Waqf Fund
- Ehsan Waqf Fund
As follows: Participating in the IPO of Specialized Medical Company whereas SNB Capital Company is the Lead Manager, one of the Financial Advisors, Bookrunners and Underwriters. The fund board approval was obtained.
SNB Capital Saudi Trading Equity Fund
SNB Capital GCC Trading Equity Fund
SNB Capital GCC Growth and Income Fund
SNB Capital Freestyle Saudi Equity Fund
SNB Capital Saudi Small and Mid-Cap Equity Fund
SNB Capital Saudi Large-Mid Cap Equity
Fund
SNB Capital Saudi Nomu Market Fund
SNB Capital Al Ataa Saudi Equity Fund
SNB Capital Healthcare & Education Sectors Fund
SNB Capital Arab Markets Equity Fund
SNB Capital King Saud University Waqf Fund
Ehsan Waqf Fund
As follows: Participating in the IPO of Specialized Medical Company whereas SNB Capital Company is the Lead Manager, one of the Financial Advisors, Bookrunners and Underwriters. The fund board approval was obtained.
SNB Capital Company announces a conflict of interest in the following funds:
- SNB Capital Saudi Trading Equity Fund
- SNB Capital GCC Trading Equity Fund
- SNB Capital GCC Growth and Income Fund
- SNB Capital Freestyle Saudi Equity Fund
- SNB Capital Saudi Small and Mid-Cap Equity Fund
- SNB Capital Saudi Large-Mid Cap Equity
Fund
- SNB Capital Saudi Nomu Market Fund
- SNB Capital Al Ataa Saudi Equity Fund
- SNB Capital Healthcare & Education Sectors Fund
- SNB Capital Arab Markets Equity Fund
- SNB Capital King Saud University Waqf Fund
- Ehsan Waqf Fund
As follows: Participating in the IPO of Specialized Medical Company whereas SNB Capital Company is the Lead Manager, one of the Financial Advisors, Bookrunners and Underwriters. The fund board approval was obtained.
SNB Capital Company Announces the Publication of ACWA Power Company’s Rights Issue Prospectus
With reference to the Capital Market Authority (the "CMA") resolution approving ACWA Power Company ("ACWA Power" or the "Company") request to increase its capital by way of rights issue valued at SAR (7,124,999,700), and with reference to ACWA Power's announcement published on the Saudi Stock Exchange (Tadawul) website on 08/12/1446H (corresponding to 04/06/2025G) in relation to inviting the shareholders to attend the extraordinary general assembly meeting which includes increasing the Company's capital scheduled on Monday 05/01/1447H (corresponding to 30/06/2025G), SNB Capital would like to announce the publication of the rights issue prospectus through the following links:
Arabic Prospectus (https://cma.org.sa/Market/Prospectuses/Documents/Acwa_Power.pdf [cma.org.sa])
English Prospectus (https://cma.org.sa/en/Market/Prospectuses/Documents/Acwa_Power.pdf [cma.org.sa])
The Company will announce the proposed details related to the number of new shares, offer price and the resulting share capital increase post market close on the extraordinary general assembly meeting day and before the extraordinary general assembly meeting, and present such details related to the number of new shares, offer price and the resulting share capital increase to the shareholders during the extraordinary general assembly meeting for approval. The subscription to the rights issue shares will be in accordance with the subscription terms and conditions set out in the published prospectus.
An investment decision based on the Company's board recommendation to increase its capital or the CMA's approval without carefully reading the rights issue prospectus or fully reviewing its content may involve high risk. Therefore, investors should carefully read the prospectus, which contains detailed information on the Company, the offering and risk factors. Thus, providing investors the ability to evaluate the viability of investing in the offering, taking into considerations the associated risks. If the prospectus proves difficult to understand, it is recommended to consult with an authorized financial advisor prior to any investment decision.
With reference to the Capital Market Authority (the "CMA") resolution approving ACWA Power Company ("ACWA Power" or the "Company") request to increase its capital by way of rights issue valued at SAR (7,124,999,700), and with reference to ACWA Power's announcement published on the Saudi Stock Exchange (Tadawul) website on 08/12/1446H (corresponding to 04/06/2025G) in relation to inviting the shareholders to attend the extraordinary general assembly meeting which includes increasing the Company's capital scheduled on Monday 05/01/1447H (corresponding to 30/06/2025G), SNB Capital would like to announce the publication of the rights issue prospectus through the following links:
CMA
ACWA Power
Company
Arabic Prospectus (https://cma.org.sa/Market/Prospectuses/Documents/Acwa_Power.pdf [cma.org.sa])
Arabic Prospectus
(https://cma.org.sa/Market/Prospectuses/Documents/Acwa_Power.pdf [cma.org.sa])
https://cma.org.sa/Market/Prospectuses/Documents/Acwa_Power.pdf [cma.org.sa])
https://cma.org.sa/Market/Prospectuses/Documents/Acwa_Power.pdf [cma.org.sa]
English Prospectus (https://cma.org.sa/en/Market/Prospectuses/Documents/Acwa_Power.pdf [cma.org.sa])
English Prospectus
(https://cma.org.sa/en/Market/Prospectuses/Documents/Acwa_Power.pdf [cma.org.sa])
https://cma.org.sa/en/Market/Prospectuses/Documents/Acwa_Power.pdf [cma.org.sa]
https://cma.org.sa/en/Market/Prospectuses/Documents/Acwa_Power.pdf [cma.org.sa]
The Company will announce the proposed details related to the number of new shares, offer price and the resulting share capital increase post market close on the extraordinary general assembly meeting day and before the extraordinary general assembly meeting, and present such details related to the number of new shares, offer price and the resulting share capital increase to the shareholders during the extraordinary general assembly meeting for approval. The subscription to the rights issue shares will be in accordance with the subscription terms and conditions set out in the published prospectus.
An investment decision based on the Company's board recommendation to increase its capital or the CMA's approval without carefully reading the rights issue prospectus or fully reviewing its content may involve high risk. Therefore, investors should carefully read the prospectus, which contains detailed information on the Company, the offering and risk factors. Thus, providing investors the ability to evaluate the viability of investing in the offering, taking into considerations the associated risks. If the prospectus proves difficult to understand, it is recommended to consult with an authorized financial advisor prior to any investment decision.
Arabic Prospectus (https://cma.org.sa/Market/Prospectuses/Documents/Acwa_Power.pdf [cma.org.sa])
English Prospectus (https://cma.org.sa/en/Market/Prospectuses/Documents/Acwa_Power.pdf [cma.org.sa])
The Company will announce the proposed details related to the number of new shares, offer price and the resulting share capital increase post market close on the extraordinary general assembly meeting day and before the extraordinary general assembly meeting, and present such details related to the number of new shares, offer price and the resulting share capital increase to the shareholders during the extraordinary general assembly meeting for approval. The subscription to the rights issue shares will be in accordance with the subscription terms and conditions set out in the published prospectus.
An investment decision based on the Company's board recommendation to increase its capital or the CMA's approval without carefully reading the rights issue prospectus or fully reviewing its content may involve high risk. Therefore, investors should carefully read the prospectus, which contains detailed information on the Company, the offering and risk factors. Thus, providing investors the ability to evaluate the viability of investing in the offering, taking into considerations the associated risks. If the prospectus proves difficult to understand, it is recommended to consult with an authorized financial advisor prior to any investment decision.
With reference to the Capital Market Authority (the "CMA") resolution approving ACWA Power Company ("ACWA Power" or the "Company") request to increase its capital by way of rights issue valued at SAR (7,124,999,700), and with reference to ACWA Power's announcement published on the Saudi Stock Exchange (Tadawul) website on 08/12/1446H (corresponding to 04/06/2025G) in relation to inviting the shareholders to attend the extraordinary general assembly meeting which includes increasing the Company's capital scheduled on Monday 05/01/1447H (corresponding to 30/06/2025G), SNB Capital would like to announce the publication of the rights issue prospectus through the following links:
CMA
ACWA Power
Company
Arabic Prospectus (https://cma.org.sa/Market/Prospectuses/Documents/Acwa_Power.pdf [cma.org.sa])
Arabic Prospectus
(https://cma.org.sa/Market/Prospectuses/Documents/Acwa_Power.pdf [cma.org.sa])
https://cma.org.sa/Market/Prospectuses/Documents/Acwa_Power.pdf [cma.org.sa])
https://cma.org.sa/Market/Prospectuses/Documents/Acwa_Power.pdf [cma.org.sa]
English Prospectus (https://cma.org.sa/en/Market/Prospectuses/Documents/Acwa_Power.pdf [cma.org.sa])
English Prospectus
(https://cma.org.sa/en/Market/Prospectuses/Documents/Acwa_Power.pdf [cma.org.sa])
https://cma.org.sa/en/Market/Prospectuses/Documents/Acwa_Power.pdf [cma.org.sa]
https://cma.org.sa/en/Market/Prospectuses/Documents/Acwa_Power.pdf [cma.org.sa]
The Company will announce the proposed details related to the number of new shares, offer price and the resulting share capital increase post market close on the extraordinary general assembly meeting day and before the extraordinary general assembly meeting, and present such details related to the number of new shares, offer price and the resulting share capital increase to the shareholders during the extraordinary general assembly meeting for approval. The subscription to the rights issue shares will be in accordance with the subscription terms and conditions set out in the published prospectus.
An investment decision based on the Company's board recommendation to increase its capital or the CMA's approval without carefully reading the rights issue prospectus or fully reviewing its content may involve high risk. Therefore, investors should carefully read the prospectus, which contains detailed information on the Company, the offering and risk factors. Thus, providing investors the ability to evaluate the viability of investing in the offering, taking into considerations the associated risks. If the prospectus proves difficult to understand, it is recommended to consult with an authorized financial advisor prior to any investment decision.